# Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old

> **NCT02432911** · NA · UNKNOWN · sponsor: **Jianxiang Wang** · enrollment: 300 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** CAG regimen (Aclacinomycin, cytarabine, with/w/o G-CSF)
- **DRUG:** low dose cytarabine

## Key facts

- **NCT ID:** NCT02432911
- **Lead sponsor:** Jianxiang Wang
- **Sponsor class:** UNKNOWN
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2018-05
- **Final completion:** 2021-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432911, "Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02432911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*